Shalby Limited Increases Shareholding in PK Healthcare to 91.13% Through Rights Issue

Shalby Limited has strengthened its position in subsidiary PK Healthcare Private Limited (PKHPL) by increasing its shareholding from 87.26% to 91.13% through a rights issue completed on February 28, 2026. The healthcare company invested ₹59,60,19,500 to acquire additional equity shares, reinforcing its strategic presence in the Delhi/NCR healthcare market. Rights Issue Details The rights issue involved the allotment of 5,96,01,950 equity shares of face value ₹10 each at a price of ₹10 per share. The issue was offered to all existing shareholders in the ratio of 1 new equity share for every 2 existing equity shares held as on the record date of January 24, 2026. Parameter: Details Shares Allotted: 5,96,01,950 equity shares Face Value: ₹10 per share Issue Price: ₹10 per share Total Consideration: ₹59,60,19,500 Rights Ratio: 1:2 Record Date: January 24, 2026 Shareholding Changes Following the rights issue completion, Shalby's shareholding in PKHPL has increased significantly, demonstrating the company's commitment to expanding its subsidiary operations. Shareholding Period: Number of Shares Percentage Pre-Issue: 11,92,03,900 equity shares 87.26% Post-Issue: 17,88,05,850 equity shares 91.13% The subsidiary's paid-up share capital post-allotment stands at 19,62,15,850 equity shares of ₹10 each, amounting to ₹196,21,58,500. PK Healthcare Background and Performance PK Healthcare Private Limited was acquired by Shalby in January 2024 as part of the company's strategy to accelerate its presence in the Delhi/NCR region. The acquisition aimed to scale up international business operations and deliver quality healthcare services in northern India. The subsidiary has demonstrated consistent financial growth over the past three years: Financial Year: Turnover FY 2022-23: ₹67.36 crore FY 2023-24: ₹87.13 crore FY 2024-25: ₹91.19 crore Fund Utilization The funds raised through the rights issue will be deployed for multiple strategic purposes to strengthen PKHPL's operational capabilities. The company has outlined the following utilization areas: Repayment of existing debt obligations Working capital requirements General corporate purposes This capital infusion is expected to support the subsidiary's continued growth trajectory and enhance its ability to provide comprehensive and advanced medical facilities to patients in the northern region. The transaction represents Shalby's ongoing commitment to expanding its healthcare network and strengthening its market position through strategic investments in subsidiary operations. Shalby Limited has issued a postal ballot notice for the re-appointment of Mr. Shyamal Shivkumar Joshi as an Independent Director for a second consecutive term of 5 years. The Board of Directors had previously approved this decision at their meeting held on February 11, 2026, which commenced at 5:58 p.m. and concluded at 6:45 p.m. Postal Ballot Notice and E-voting Details The company has sent the postal ballot notice electronically to all members on February 17, 2026, whose names appeared in the Register of Members as on the cut-off date of Friday, February 13, 2026. The notice is also available on the company's website at www.shalby.org . Parameter: Details Notice Date: February 17, 2026 Cut-off Date: February 13, 2026 E-voting Service Provider: National Securities Depository Limited (NSDL) E-voting Event Number: 138387 Website Link: https://evoting.nsdl.com E-voting Schedule and Process Shareholders can cast their votes through remote e-voting facility during the specified period. The company has engaged NSDL to provide secure electronic voting services to all members. Voting Timeline: Date and Time E-voting Commencement: Friday, February 20, 2026 (9:00 a.m. IST) E-voting End: Saturday, March 21, 2026 (5:00 p.m. IST) Results Declaration: Within two working days from conclusion Director Re-appointment Details The re-appointment was approved based on the recommendation of the Nomination and Remuneration Committee and requires shareholder approval through the postal ballot process. The company has ensured full compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Director Information: Details Director Name: Mr. Shyamal Shivkumar Joshi DIN: 00005766 Age: 76 years Term Duration: 5 years Effective Period: May 17, 2026 to May 16, 2031 Resolution Type: Special Resolution Scrutinizer Appointment and Compliance The company has appointed Mr. Chintan Patel (CP No. 20103), Proprietor of M/s. Chintan I Patel & Associates, Practicing Company Secretaries, as the Scrutinizer to conduct the postal ballot process in a fair and transparent manner. The scrutinizer will submit the report within two working days of the e-voting conclusion. Mr. Joshi has been associated with Shalby Hospitals since 2010 and brings significant expertise in corporate strategy development, fundraising and capital management, mergers and acquisitions, taxation and regulatory compliance, and accounting and financial management. He is a commerce graduate from Gujarat University and a practicing Chartered Accountant with extensive experience across multiple domains. Source: We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better. Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians. As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.